MicroRNAs affect BCL-2 family proteins in the setting of cerebral ischemia

Yi-Bing Ouyang1, Rona G Giffard1

  • 1Department of Anesthesia, Stanford University School of Medicine, Stanford, CA 94305, USA.

Insights

The BCL-2 family regulates apoptosis and calcium (Ca2+) transmission in cerebral ischemia. MicroRNAs, like miR-29, target these proteins, influencing outcomes after stroke.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • The BCL-2 protein family is crucial for regulating apoptosis and cell death following cerebral ischemia.
  • These proteins control mitochondrial outer membrane permeabilization, a key step in programmed cell death.
  • Emerging evidence implicates BCL-2 family members in regulating calcium (Ca2+) transmission at mitochondria-associated ER membranes (MAM).

Purpose of the Study:

  • To review the multifaceted roles of BCL-2 family proteins in cerebral ischemia.
  • To summarize the known relationship between BCL-2 family proteins and stroke outcomes.
  • To highlight the regulatory role of microRNAs (miRNAs) targeting BCL-2 family proteins in cerebral ischemia.

Main Methods:

  • Literature review of existing research on BCL-2 family proteins, cerebral ischemia, and miRNAs.
  • Focus on studies investigating the interaction between miRNAs and BCL-2 family members.
  • Analysis of the specific role of miR-29 in targeting BCL-2 family proteins.

Main Results:

  • BCL-2 family proteins are central to apoptotic mechanisms after cerebral ischemia.
  • These proteins also influence Ca2+ signaling between the endoplasmic reticulum and mitochondria via MAM.
  • miRNAs, particularly miR-29, are increasingly recognized for their regulatory impact on BCL-2 family proteins in the context of cerebral ischemia.

Conclusions:

  • BCL-2 family proteins play a dual role in cerebral ischemia, affecting both apoptosis and calcium homeostasis.
  • miRNAs, especially miR-29, represent a significant regulatory layer for BCL-2 family proteins in stroke.
  • Understanding these interactions is vital for developing novel therapeutic strategies for cerebral ischemia.

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
54
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
24